Abstract

Serine protease inhibitors (serpins) family have a complex mechanism of inhibition that requires a large scale conformational change. Antithrombin (AT), a member of serpin superfamily serves as a key regulator of the blood coagulation cascade, deficiency of which leads to thrombosis. In recent years, a handful of studies have identified small compounds that retard serpin polymerization but abrogated the normal activity. Here, we screened small molecules to find potential leads that can reduce AT polymer formation. We identified simple sugar molecules that successfully blocked polymer formation without a significant loss of normal activity of AT under specific buffer and temperature conditions. Of these, trehalose proved to be most promising as it showed a marked decrease in the bead like polymeric structures of AT shown by electron microscopic analysis. A circular dichroism (CD) analysis indicated alteration in the secondary structure profile and an increased thermal stability of AT in the presence of trehalose. Guanidine hydrochloride (GdnHCl)-based unfolding studies of AT show the formation of a different intermediate in the presence of trehalose. A time-dependent fluorescence study using 1,1′-bi(4-anilino)naphthalene-5,5′-disulfonic acid (Bis-ANS) shows that trehalose affects the initial conformational change step in transition from native to polymer state through its binding to exposed hydrophobic residues on AT thus making AT less polymerogenic. In conclusion, trehalose holds promise by acting as an initial scaffold that can be modified to design similar compounds with polymer retarding propensity.

Highlights

  • Antithrombin (AT) is the main regulator of the blood coagulation cascade and acts by inhibiting various proteases like thrombin, factor IXa, factor Xa and factor XIa [1,2]

  • The process of serpin polymerization is of acute biomedical interest given the recognition that several devastating pathologies including thrombosis are etiologically correlated to serpin polymers

  • The underlying reason for most of the serpinopathies is the sophisticated mechanism of serpin inhibition that involves a large conformational change which makes it prone to conformational deformation based diseases [15,16]

Read more

Summary

Introduction

Antithrombin (AT) is the main regulator of the blood coagulation cascade and acts by inhibiting various proteases like thrombin, factor IXa, factor Xa and factor XIa [1,2]. A serpin is composed of three β-sheets (A–C), 7–9 α-helices (hA-hI) and a mobile reactive center loop (RCL) which is exposed [8,9]. This loop presents a peptide sequence as a pseudo-substrate for the target proteinase that is cleaved after docking with the enzyme [10]. Mutation resulting in polymer formation in α-1antitrypsin (AAT), neuroserpin (NEU), AT, C1 inhibitor, antichymotrypsin (ACT) and heparin cofactor II (HCF-II) can lead to pathological states like cirrhosis, emphysema, dementia, thrombosis and angioedema [16]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call